VTRLY (Vitrolife AB) Cyclically Adjusted FCF per Share: $0.58 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTRLY Vitrolife AB VTRLY
70 GF Score
Price $9.50
GF Value $18.55
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Cyclically Adjusted FCF per Share?

Vitrolife AB VTRLY 70 Cyclically Adjusted FCF per Share is $0.58 as of Jun. 2026. GuruFocus rates VTRLY with a GF Score™ of 70/100 and a GF Value™ of $18.55 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vitrolife AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.082. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.58 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Vitrolife AB's average Cyclically Adjusted FCF Growth Rate was 6.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Vitrolife AB was 23.10% per year. The lowest was 11.90% per year. And the median was 18.65% per year.

As of today (2026-08-24), Vitrolife AB's current stock price is $9.50. Vitrolife AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $0.58. Vitrolife AB's Cyclically Adjusted Price-to-FCF of today is 16.38.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vitrolife AB was 236.86. The lowest was 18.40. And the median was 89.82.


Vitrolife AB  (OTCPK:VTRLY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Vitrolife AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=9.50/0.58
=16.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vitrolife AB was 236.86. The lowest was 18.40. And the median was 89.82.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vitrolife AB Cyclically Adjusted FCF per Share Related Terms


Vitrolife AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Cyclically Adjusted FCF per Share Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.33 0.26 0.37 0.49

Vitrolife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.51 0.49 0.53 0.58

VTRLY vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Vitrolife AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Cyclically Adjusted Price-to-FCF falls into.


VTRLY
70GF Score
Vitrolife AB VTRLY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vitrolife AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.082/134.6100*134.6100
=0.082

Current CPI (Jun. 2026) = 134.6100.

Vitrolife AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.050 101.138 0.067
201612 0.079 102.022 0.104
201703 0.035 102.022 0.046
201706 0.089 102.752 0.117
201709 0.097 103.279 0.126
201712 0.121 103.793 0.157
201803 0.047 103.962 0.061
201806 0.110 104.875 0.141
201809 0.089 105.679 0.113
201812 0.119 105.912 0.151
201903 0.025 105.886 0.032
201906 0.044 106.742 0.055
201909 0.141 107.214 0.177
201912 0.105 107.766 0.131
202003 0.013 106.563 0.016
202006 0.061 107.498 0.076
202009 0.100 107.635 0.125
202012 0.189 108.296 0.235
202103 0.154 108.360 0.191
202106 0.146 108.928 0.180
202109 0.106 110.338 0.129
202112 0.000 112.486 0.000
202203 0.069 114.825 0.081
202206 0.132 118.384 0.150
202209 0.135 122.296 0.149
202212 0.118 126.365 0.126
202303 0.101 127.042 0.107
202306 0.145 129.407 0.151
202309 0.143 130.224 0.148
202312 0.123 131.912 0.126
202403 0.140 132.205 0.143
202406 0.166 132.716 0.168
202409 0.149 132.304 0.152
202412 0.180 132.987 0.182
202503 0.050 132.825 0.051
202506 0.039 133.699 0.039
202509 0.201 133.480 0.203
202512 0.127 133.390 0.128
202603 0.136 133.560 0.137
202606 0.082 134.610 0.082

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.58 mean?
Vitrolife AB (VTRLY) has a Cyclically Adjusted FCF per Share of $0.58 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Cyclically Adjusted FCF per Share too high?
Vitrolife AB's current Cyclically Adjusted FCF per Share is $0.58. Overall, Vitrolife AB has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Vitrolife AB's Cyclically Adjusted FCF per Share of $0.58 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Cyclically Adjusted FCF per Share is $0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (VTRLY) is currently considered Possible Value Trap. The stock's GF Value™ is $18.55, compared to a current price of $9.50 — trading 48.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.58. Vitrolife AB's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Vitrolife AB (VTRLY), the current Cyclically Adjusted FCF per Share is $0.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (VTRLY) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of $9.50 is trading 48.8% below its estimated GF Value™ of $18.55. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for VTRLY:

  • Cyclically Adjusted FCF per Share: $0.58
  • GF Value™: $18.55 vs. price of $9.50 (48.8% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the VTRLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
70GF Score

Get the complete analysis for VTRLY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.50
Price
$18.55
GF Value